BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 25645022)

  • 21. PKM2 contributes to cancer metabolism.
    Wong N; Ojo D; Yan J; Tang D
    Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
    Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging roles of PKM2 in cell metabolism and cancer progression.
    Luo W; Semenza GL
    Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyruvate kinase M2 interacts with DNA damage-binding protein 2 and reduces cell survival upon UV irradiation.
    Xie X; Wang M; Mei J; Hu F; Ding F; Lv L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):427-33. PubMed ID: 26410533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
    Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C
    Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analyses of the cysteine thiol oxidation of PKM2 reveal the effects of multiple oxidation on cellular oxidative stress response.
    Irokawa H; Numasaki S; Kato S; Iwai K; Inose-Maruyama A; Ohdate T; Hwang GW; Toyama T; Watanabe T; Kuge S
    Biochem J; 2021 Apr; 478(7):1453-1470. PubMed ID: 33749780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic Allosteric Mechanism of Fructose-1,6-bisphosphate and Serine for Pyruvate Kinase M2 via Dynamics Fluctuation Network Analysis.
    Yang J; Liu H; Liu X; Gu C; Luo R; Chen HF
    J Chem Inf Model; 2016 Jun; 56(6):1184-1192. PubMed ID: 27227511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in PKM2 associate with prostate cancer progression.
    Wong N; Yan J; Ojo D; De Melo J; Cutz JC; Tang D
    Cancer Invest; 2014 Aug; 32(7):330-8. PubMed ID: 24884829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics.
    Zhu S; Guo Y; Zhang X; Liu H; Yin M; Chen X; Peng C
    Cancer Lett; 2021 Apr; 503():240-248. PubMed ID: 33246091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular simulation of Tyr105 phosphorylated pyruvate kinase M2 to understand its structure and dynamics.
    Kalaiarasan P; Subbarao N; Bamezai RN
    J Mol Model; 2014 Sep; 20(9):2447. PubMed ID: 25208557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKM2, a potential target for regulating cancer.
    Li YH; Li XF; Liu JT; Wang H; Fan LL; Li J; Sun GP
    Gene; 2018 Aug; 668():48-53. PubMed ID: 29775756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
    Kachel P; Trojanowicz B; Sekulla C; Prenzel H; Dralle H; Hoang-Vu C
    BMC Cancer; 2015 Mar; 15():140. PubMed ID: 25880801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor.
    Matsuda S; Adachi J; Ihara M; Tanuma N; Shima H; Kakizuka A; Ikura M; Ikura T; Matsuda T
    Nucleic Acids Res; 2016 Jan; 44(2):636-47. PubMed ID: 26405201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CARM1 suppresses
    Abeywardana T; Oh M; Jiang L; Yang Y; Kong M; Song J; Yang Y
    J Biol Chem; 2018 Sep; 293(39):15290-15303. PubMed ID: 30131339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
    Chaneton B; Gottlieb E
    Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
    Dando I; Cordani M; Donadelli M
    IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.